MedTrace Logo

the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block

NCT02961361 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-02-15

No results posted yet for this study

Summary

Dexmedetomidine is an α-2 adrenoreceptor agonist and has been extensively used through intravenous infusion，in order to improved the quality of block in regional anesthesia. In this prospective, randomized study, the authors focus on the effect of dexmedetomidine mixed with ropivacaine in coracoid approach brachial plexus block.

Conditions

  • Injury of Upper Limb

Interventions

DRUG

ropivacaine

40 ml 0.375% ropivacaine was injected after Locating brachial plexus.

DRUG

ropivacaine mixed with dexmedetomidine

40 ml 0.375% ropivacaine mixed with dexmedetomidine was injected after Locating brachial plexus.

Sponsors & Collaborators

  • The First Hospital of Qinhuangdao

    lead OTHER_GOV

Principal Investigators

  • wensheng he, MD · Hebei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-12
Primary Completion
2017-03-30
Completion
2017-05-25

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02961361 on ClinicalTrials.gov